We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Urgent Product Recall.
- Abstract
The article reports that American Pharmaceutical Partners Inc. (APP) has initiated a product recall for fluorouracil injection, USP, 50 mg/ml. The recall was initiated because invisible glass particles composed of silica and aluminum are potentially present in the vials. Only Code 101710 is susceptible to this type of glass breakdown. APP will provide fluorouracil 10 ml vials. To ensure that healthcare professionals have access to the appropriate filters, APP will temporarily supply 5 micron filter needles with the fluorouracil 10 ml vials.
- Subjects
PRODUCT recall; FLUOROURACIL; AMERICAN Pharmaceutical Partners Inc.; ANTINEOPLASTIC agents; MEDICAL care; PRODUCT liability
- Publication
ONS News, 2005, Vol 20, Issue 12, p3
- ISSN
0890-5215
- Publication type
Article